TABLE 1.
Patient characteristics
| N=112 | |
|---|---|
| Age (yrs) | 47.58±15.92 |
| Male gender | 90 (82%) |
| Indication for transplant | |
| Ischemic cardiomyopathy | 32 (30%) |
| Dilated cardiomyopathy | 54 (50%) |
| Other | 22 (20%) |
| Time transplant-blood test (yrs) | 5.27±3.35 |
| Donor age (yrs) | 30.06±12.56 |
| Cold ischemic time (min) | 164.57±50.02 |
| BMI | 28.73±6.25 |
| ACE inhibitor | 40 (37%) |
| Statin | 95 (87%) |
| Cyclosporine | 95 (84%) |
| Tacrolimus | 18 (16%) |
| Azathioprine | 75 (68%) |
| Mycophenolate mofetil | 37 (32%) |
| Prednisone | 35 (32%) |
| History of CMV infection | 27 (25%) |
| Hypertension | 45 (41%) |
| Diabetes mellitus | 40 (37%) |
| Rejection episodes (>1B) | 67 (61%) |
| Creatinine (mg/dL) | 2.18±1.16 |
| Glucose (mg/dL) | 100 (92.0–109.75)a |
| Triglycerides (mg/dL) | 182.19±78.48 |
| Total cholesterol (mg/dL) | 175.46±34.31 |
| LDL-cholesterol (mg/dL) | 99.71±29.64 |
| LDL>130 mg/dL, n (%) | 14 (13.5%) |
| LDL particle size (Å) | 271 (266–275)a |
| HDL-cholesterol (mg/dL) | 48.80±15.51 |
| IDL (mg/dL) | 33.70±10.83 |
| Lp-PLA2 (ng/mL) | 201 (174–251)a |
| CRP (mg/L) | 1.40 (0.56–3.45)a |
a
Median and IQR.